JS

Josh Stevens

Technology & Healthcare Executive | Independent Board Member

United States

Invests in

  • Min Investment:

    $5,000,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $7,500,000.00

Work Experience

  • Managing Partner

    2012

    Healthcare strategy & management consulting. Emphasis on PE backed companies with an emphasis on value-based-care, population health, food-as-medicine, and cardio-metabolic chronic-condition management.

  • Advisor to the CEO

    2022

    Working with the CEO and leadership team, advise on GTM strategy, org development, payer sales, and population health approach to Food As Medicine, focused on Medicare and Medicaid markets.

  • Chair, Pension Fund Audit Committee

    2018

    Member of the Investment, Audit, and Compliance committees of the Board of Directors. The Board of Pensions administers the Healthcare Benefits and Pension funds totaling $12 billion.

2017 - 2023

  • Healthcare & Health IT Investments

    2017 - 2023

    Healthcare & Health IT

2017 - 2022

  • President & Chief Growth Officer

    2017 - 2022

    DayTwo's outcomes-based model uses a gut microbiome profile to enable a path to remission for patients with type 2 diabetes. DayTwo serves primarily employers and payers to deliver personalized care plans and care coordination that enables medication reduction, lower A1C, and improved weight management.

  • CEO, Keas (Acquired by Virgin Pulse)

    2012 - 2016

2008 - 2012

  • CRO, YouSendIt (Acquired by OpenText & Western Digital)

    2008 - 2012

2007 - 2008

  • SVP Corporate Development, TicketsNow (Acquired by Ticketmaster)

    2007 - 2008

1997 - 2007

  • GM e-Commerce

    1997 - 2007

1995 - 1997

  • Credit Risk Analyst

    1995 - 1997